Structural Formula (Eno0g 0000 01)
Enoxaparin Sodium Injection
Product Images NDC 68001-641
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 68001-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structural Formula (Eno0g 0000 02)
Figure 1 (Eno0g 0000 03)
This text provides a detailed breakdown of subgroup analysis based on various factors such as sex, age, infarct location, diabetes status, prior MI history, type of fibrinolytic agent, time to treatment, and outcomes including PCl in 30 days, relative risk, number of patients, UFH versus Enoxaparin comparison, and reduction in risk percentage. The information can be utilized to understand how different variables impact outcomes in a specific setting.*
Figure 2 (Eno0g 0000 04)
This is a data table that shows information related to Enoxaparin and UFH (Unfractionated Heparin) up to one year. It includes time intervals, number at risk, and time to death or myocardial re-infarction. The text also mentions Log-Rank Test results for two scenarios. The results indicate very significant differences with a p-value of less than 0.0001 for one test and 0.0111 for the other.*
Enoxaparin Inj Multi Dose Carton (Enox Carton Dl)
This text is the label information for Enoxaparin Sodium Injection. It provides details about the dosage, administration, storage instructions, warnings, and manufacturer information for this medication. Enoxaparin is used for subcutaneous or intravenous injection and each 3mL multi-dose vial contains 300mg of the active ingredient. The medication is derived from porcine intestinal mucosa and should be stored at a temperature between 15°C to 30°C. The label also includes dosage and administration instructions, as well as warnings to keep out of reach of children and not to store the vial for more than 28 days after first use. The manufacturer is Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd from China.*
Enoxaparin Inj Multi Dose Vial Label (Enox Vial Dl)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
